跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVA-ARIPIPRAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RIVA-ARIPIPRAZOLE
Authorized
STANDARD
RIVA-ARIPIPRAZOLE
laboratoire riva inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
cf81daff2670f31c
Company
laboratoire riva inc.
Type
Standard
Approval Details
Approval Id
cf81daff2670f31c
Drug Approval Canada Name
RIVA-ARIPIPRAZOLE
Product Name
RIVA-ARIPIPRAZOLE
Status
Marketed
Status Date
2018-08-22
Original Market Date
2018-08-22
Din
02479389
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.08.04
Atc Original
N05AX12 ARIPIPRAZOLE
Atc Name
n 05 ax 12
Aig Number
0152514004
Company Name
laboratoire riva inc.
Company Address
660 Boul. Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
ARIPIPRAZOLE
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
cf81daff2670f31c
Type
Standard
Back to Health Canada Approvals